Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract LB076: Targeting an aging-related molecule overcomes resistance to anti-PD1 treatment of cancer

Chie Kudo-Saito, Hiroshi Imazeki, Hirokazu Shoji, Narikazu Boku

Cancer Res (2024) 84 (7_Supplement): LB076.

https://doi.org/10.1158/1538-7445.AM2024-LB076

Published: 05 April 2024

View articletitled, Abstract LB076: Targeting an aging-related molecule overcomes resistance to anti-PD1 treatment of cancer

Journal Articles

Abstract 1060: Phosphoproteomic subtyping of gastric cancer reveals dynamic transformation with chemotherapy

Jun Adachi, Masahiko Aoki, Hidekazu Hirano, Yuichi Abe, Ryohei Narumi, Kazufumi Honda, Takeshi Tomonaga, Kenji Mizuguchi, Takaki Yoshikawa, Narikazu Boku

Cancer Res (2023) 83 (7_Supplement): 1060.

https://doi.org/10.1158/1538-7445.AM2023-1060

Published: 04 April 2023

View articletitled, Abstract 1060: Phosphoproteomic subtyping of gastric cancer reveals dynamic transformation with chemotherapy

Journal Articles

Abstract 3772: Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens

Jun ADACHI, Yuichi Abe, Hidekazu Hirano, Hirokazu Shoji, Daigo Gunji, Kazufumi Honda, Narikazu Boku, Takeshi Tomonaga

Cancer Res (2020) 80 (16_Supplement): 3772.

https://doi.org/10.1158/1538-7445.AM2020-3772

Published: 15 August 2020

View articletitled, Abstract 3772: Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens

Journal Articles

IL33 Is a Key Driver of Treatment Resistance of Cancer

Chie Kudo-Saito, Takahiro Miyamoto, Hiroshi Imazeki, Hirokazu Shoji, Kazunori Aoki, Narikazu Boku

Cancer Res (2020) 80 (10): 1981–1990.

https://doi.org/10.1158/0008-5472.CAN-19-2235

Published: 15 May 2020

View articletitled, IL33 Is a Key Driver of Treatment Resistance of Cancer

Includes: Supplementary data

Journal Articles

Abstract 3882: Exposure-toxicity analysis of unbound regorafenib and its active metabolites by dose escalation strategy with low starting dose in patients with colorectal cancer

Cancer Res (2019) 79 (13_Supplement): 3882.

https://doi.org/10.1158/1538-7445.AM2019-3882

Published: 01 July 2019

View articletitled, Abstract 3882: Exposure-toxicity analysis of unbound regorafenib and its active metabolites by dose escalation strategy with low starting dose in patients with colorectal cancer

Journal Articles

Abstract CT052: Phase I study of the anti-heparin binding-EGF antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer

Takako E. Nakajima, Narikazu Boku, Hiroyuki Arai, Takuro Mizukami, Yoshiki Horie, Naoki Izawa, Mami Hirakawa, Takashi Ogura, Takashi Tsuda, Yu Sunakawa

Cancer Res (2018) 78 (13_Supplement): CT052.

https://doi.org/10.1158/1538-7445.AM2018-CT052

Published: 01 July 2018

View articletitled, Abstract CT052: Phase I study of the anti-heparin binding-EGF antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer

Journal Articles

Abstract 3818: Identification of a FGFR3-TACC3 fusion in esophageal cancer

Takuro Mizukami, Kazuko Sakai, Saeko Naruki, Tomoko Taniyama, Yoshiki Horie, Naoki Izawa, Takashi Tsuda, Takashi Fujino, Narikazu Boku, Hiroshi Yasuda, Tetsu Fukunaga, Takako Eguchi Nakajima, Kazuto Nishio

Cancer Res (2017) 77 (13_Supplement): 3818.

https://doi.org/10.1158/1538-7445.AM2017-3818

Published: 01 July 2017

View articletitled, Abstract 3818: Identification of a FGFR3-TACC3 fusion in esophageal cancer

Journal Articles

Abstract 668: Evaluation of α-1-acid glycoprotein as a prognostic marker and as a predictive biomarker for severe neutropenia induced by docetaxel in esophageal carcinoma patients

Yusuke Sasaki, Ken Kato, Hidekazu Hirano, Hirokazu Shoji, Yoshitaka Honma, Satoru Iwasa, Atsuo Takashima, Tetsuya Hamaguchi, Kengo Nagashima, Narikazu Boku

Cancer Res (2017) 77 (13_Supplement): 668.

https://doi.org/10.1158/1538-7445.AM2017-668

Published: 01 July 2017

View articletitled, Abstract 668: Evaluation of α-1-acid glycoprotein as a prognostic marker and as a predictive biomarker for severe neutropenia induced by docetaxel in esophageal carcinoma patients

Journal Articles

Abstract 5456: FGF9 gene amplification can induce resistance to anti-EGFR therapy in colorectal cancer

Takuro Mizukami, Yosuke Togashi, Eri Banno, Masato Terashima, Marco A de velasco, Kazuko Sakai, Yoshihiko Fujita, Shuta Tomida, Takako Eguchi Nakajima, Narikazu Boku, Kazuto Nishio

Cancer Res (2015) 75 (15_Supplement): 5456.

https://doi.org/10.1158/1538-7445.AM2015-5456

Published: 01 August 2015

View articletitled, Abstract 5456: FGF9 gene amplification can induce resistance to anti-EGFR therapy in colorectal cancer

Journal Articles

Abstract 4248: Predictive signature of response to EGFR tyrosine kinase inhibitors in non-small-cell lung cancer cells by tyrosine kinase activity profiling

Naoki Izawa, Masakuni Serizawa, Faris Naji, Rik de Wijn, Riet Hilhorst, Rob Ruijtenbeek, Hirofumi Yasui, Takako Nakajima, Narikazu Boku, Yasuhiro Koh

Cancer Res (2014) 74 (19_Supplement): 4248.

https://doi.org/10.1158/1538-7445.AM2014-4248

Published: 01 October 2014

View articletitled, Abstract 4248: Predictive signature of response to EGFR tyrosine kinase inhibitors in non-small-cell lung cancer cells by tyrosine kinase activity profiling

Journal Articles

Abstract 4655: In vitro tyrosine kinase activity profiling to identify molecular targets and predictive biomarkers in gastric cancer cell lines.

Yasuhiro Koh, Masakuni Serizawa, Rik de Wijn, Riet Hilhorst, Takako Nakajima, Hirofumi Yasui, Kazuyoshi Yanagihara, Martijn Dankers, Rob Ruijtenbeek, Narikazu Boku

Cancer Res (2013) 73 (8_Supplement): 4655.

https://doi.org/10.1158/1538-7445.AM2013-4655

Published: 15 April 2013

View articletitled, Abstract 4655: In vitro tyrosine kinase activity profiling to identify molecular targets and predictive biomarkers in gastric cancer cell lines.

Journal Articles

HERC2 Interacts with Claspin and Regulates DNA Origin Firing and Replication Fork Progression

Naoki Izawa, Wenwen Wu, Ko Sato, Hiroyuki Nishikawa, Akihiro Kato, Narikazu Boku, Fumio Itoh, Tomohiko Ohta

Cancer Res (2011) 71 (17): 5621–5625.

https://doi.org/10.1158/0008-5472.CAN-11-0385

Published: 30 August 2011

View articletitled, HERC2 Interacts with Claspin and Regulates DNA Origin Firing and Replication Fork Progression

Includes: Supplementary data

Journal Articles

Abstract 4468: In vitro evaluation of multi-targeted kinase inhibitors in scirrhous gastric cancer cell lines by tyrosine kinase activity profiling

Yasuhiro Koh, Masakuni Serizawa, Rik de Wijn, Riet Hilhorst, Takako Nakajima, Hirofumi Yasui, Kazuyoshi Yanagihara, Martijn Dankers, Rob Ruijtenbeek, Narikazu Boku

Cancer Res (2011) 71 (8_Supplement): 4468.

https://doi.org/10.1158/1538-7445.AM2011-4468

Published: 15 April 2011

View articletitled, Abstract 4468: In vitro evaluation of multi-targeted kinase inhibitors in scirrhous gastric cancer cell lines by tyrosine kinase activity profiling

Journal Articles

Abstract 4430: A novel mitotic kinesin Eg5 inhibitor exerts the growth-inhibitory effect in cancer cells in a manner independent of induction of monoastral formation but dependent on KRAS mutation status

Takehito Shukuya, Hye-Ran Lee, Masakuni Serizawa, Naohisa Ogo, Akira Asai, Narikazu Boku, Nobuyuki Yamamoto, Yasuhiro Koh

Cancer Res (2010) 70 (8_Supplement): 4430.

https://doi.org/10.1158/1538-7445.AM10-4430

Published: 15 April 2010

View articletitled, Abstract 4430: A novel mitotic kinesin Eg5 inhibitor exerts the growth-inhibitory effect in cancer cells in a manner independent of induction of monoastral formation but dependent on KRAS mutation status

Journal Articles

Suppression of T-Lymphoma Cell Apoptosis by Monoclonal Antibodies Raised against Cell Surface Adhesion Molecules

Naoya Fujita, Shiro Kataoka, Mikihiko Naito, Yuji Heike, Narikazu Boku, Motowo Nakajima, Takashi Tsuruo

Cancer Res (1993) 53 (20): 5022–5027.

Published: 01 October 1993

View articletitled, Suppression of T-Lymphoma Cell Apoptosis by Monoclonal Antibodies Raised against Cell Surface Adhesion Molecules

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract LB076: Targeting an aging-related molecule overcomes resistance to anti-PD1 treatment of cancer

Abstract 1060: Phosphoproteomic subtyping of gastric cancer reveals dynamic transformation with chemotherapy

Abstract 3772: Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens

IL33 Is a Key Driver of Treatment Resistance of Cancer

Abstract 3882: Exposure-toxicity analysis of unbound regorafenib and its active metabolites by dose escalation strategy with low starting dose in patients with colorectal cancer

Abstract CT052: Phase I study of the anti-heparin binding-EGF antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer

Abstract 3818: Identification of a FGFR3-TACC3 fusion in esophageal cancer

Abstract 668: Evaluation of α-1-acid glycoprotein as a prognostic marker and as a predictive biomarker for severe neutropenia induced by docetaxel in esophageal carcinoma patients

Abstract 5456: FGF9 gene amplification can induce resistance to anti-EGFR therapy in colorectal cancer

Abstract 4248: Predictive signature of response to EGFR tyrosine kinase inhibitors in non-small-cell lung cancer cells by tyrosine kinase activity profiling

Abstract 4655: In vitro tyrosine kinase activity profiling to identify molecular targets and predictive biomarkers in gastric cancer cell lines.

HERC2 Interacts with Claspin and Regulates DNA Origin Firing and Replication Fork Progression

Abstract 4468: In vitro evaluation of multi-targeted kinase inhibitors in scirrhous gastric cancer cell lines by tyrosine kinase activity profiling

Abstract 4430: A novel mitotic kinesin Eg5 inhibitor exerts the growth-inhibitory effect in cancer cells in a manner independent of induction of monoastral formation but dependent on KRAS mutation status

Suppression of T-Lymphoma Cell Apoptosis by Monoclonal Antibodies Raised against Cell Surface Adhesion Molecules

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only